For example, FGA, an adverse risk marker in our model, has been shown to predict poor survival in lung squamous cell carcinoma (LUSC), the second common subtype of NSCLC, in multiple patient cohorts.72 The gene discussed is FGA; the disease is non-small cell lung carcinoma.